AU2001237158A1 - A dominant selectable marker for gene transformation and disruption in yeasts - Google Patents

A dominant selectable marker for gene transformation and disruption in yeasts

Info

Publication number
AU2001237158A1
AU2001237158A1 AU2001237158A AU3715801A AU2001237158A1 AU 2001237158 A1 AU2001237158 A1 AU 2001237158A1 AU 2001237158 A AU2001237158 A AU 2001237158A AU 3715801 A AU3715801 A AU 3715801A AU 2001237158 A1 AU2001237158 A1 AU 2001237158A1
Authority
AU
Australia
Prior art keywords
yeasts
disruption
selectable marker
dominant selectable
gene transformation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237158A
Other languages
English (en)
Inventor
Howard Bussey
John Davison
Terry Roemer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU2001237158A1 publication Critical patent/AU2001237158A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001237158A 2000-02-18 2001-02-19 A dominant selectable marker for gene transformation and disruption in yeasts Abandoned AU2001237158A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18346200P 2000-02-18 2000-02-18
US60/183,462 2000-02-18
PCT/CA2001/000194 WO2001061019A2 (fr) 2000-02-18 2001-02-19 Marqueur dominant selectionnable pour la transformation de genes et la dissociation dans les levures

Publications (1)

Publication Number Publication Date
AU2001237158A1 true AU2001237158A1 (en) 2001-08-27

Family

ID=22672888

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237158A Abandoned AU2001237158A1 (en) 2000-02-18 2001-02-19 A dominant selectable marker for gene transformation and disruption in yeasts

Country Status (4)

Country Link
US (1) US6562595B2 (fr)
AU (1) AU2001237158A1 (fr)
CA (1) CA2400534C (fr)
WO (1) WO2001061019A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783985B1 (en) 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery
US20030180953A1 (en) * 2000-12-29 2003-09-25 Elitra Pharmaceuticals, Inc. Gene disruption methodologies for drug target discovery
US20030119013A1 (en) * 2001-04-23 2003-06-26 Bo Jiang Identification of essential genes of Aspergillus fumigatus and methods of use
WO2005054511A1 (fr) * 2003-12-02 2005-06-16 Daikin Industries, Ltd. Methode d'analyse d'agent chimique a l'aide d'une souche genetique disloquee
US7501275B2 (en) * 2004-10-27 2009-03-10 The United States Of America As Represented By The Secretary Of Agriculture Yeast transformation system
IL241462A0 (en) 2015-09-10 2015-11-30 Yeda Res & Dev Heterologous engineering of betalain pigments in plants
US20220217934A1 (en) 2018-09-06 2022-07-14 Yeda Research And Development Co. Ltd. Cellulose-synthase-like enzymes and uses thereof
CN112813091A (zh) * 2021-02-03 2021-05-18 山东农业大学 Nat1基因作为筛选标记在卵菌遗传转化中的应用
WO2023245158A2 (fr) * 2022-06-16 2023-12-21 Brown University Combinaison d'adjuvants et d'antibiotiques pour la sélection d'espèces microbiennes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650553A (en) * 1992-06-16 1997-07-22 The Trustees Of The University Of Pennsylvania Plant genes for sensitivity to ethylene and pathogens
FR2718152B1 (fr) * 1994-04-05 1996-06-28 Lvmh Rech Procédé de sélection de cellules eucaryotes transformées et cellules obtenues.
CA2218446A1 (fr) * 1997-12-12 1999-06-12 Mcgill University Nouveau candida albicans kre9 et applications
AU4531300A (en) * 1999-05-05 2000-11-21 Mcgill University Identification of LTiGTcandida albicansLT/iGT essential fungal specific genes and use thereof in antifungal drug discovery

Also Published As

Publication number Publication date
CA2400534C (fr) 2012-06-19
CA2400534A1 (fr) 2001-08-23
WO2001061019A3 (fr) 2002-09-26
WO2001061019A2 (fr) 2001-08-23
US20010031724A1 (en) 2001-10-18
WO2001061019A9 (fr) 2002-07-18
US6562595B2 (en) 2003-05-13

Similar Documents

Publication Publication Date Title
AU2001294922A1 (en) Automated bioculture and bioculture experiments system
AU2002231052A1 (en) Technical standard review and approval
AU2002213355A1 (en) Wireless asp systems and methods
AU2002220473A1 (en) Toughened plastics and its preparation method
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU2002223178A1 (en) Easy open end and can for powders
AU2000262575A1 (en) Method for localising direction and localisation arrangement
AU2001237158A1 (en) A dominant selectable marker for gene transformation and disruption in yeasts
AU2002243386A1 (en) Rf2a and rf2b transcription factors
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU7458201A (en) Laminate and use thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001265026A1 (en) Oilseed extract products and uses
AU2001236718A1 (en) Bioreactor and related method
AU2001297738A1 (en) Gene delivery device and gene delivery method
AU2001274354A1 (en) Spreads with viable bacterial culture and preparation thereof
AU2001269276A1 (en) Drills and their manufacture
AU2002223344A1 (en) Sputum fixative and methods and uses therefor
AU2001237592A1 (en) Enzymes and uses relating thereto
AU2001284288A1 (en) Plant resistance gene
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2002256556A1 (en) Sea-trosy and related methods
AU2002355155A1 (en) Methods for gene disruption and uses thereof
AU2001274256A1 (en) Plant resistance gene
AUPR295001A0 (en) A gene and uses therefor